And for gene expression study, least three independent parallel experiments were taken, organized, and calculated using Microsoft Excel 2010 and then analyzed using SPSS software (IBM SPSS Statistics, Version 20), p-values were calculated using independent samples t-test, p < .05 indicates significant, p < .01 indicates highly significant, and finally Plotting was performed using the software ORIGIN 2018 (asterisks indicate significant differences: *P < .05, **P < .01).
Excerpts
borderline significanceP = 0.05
The GCs/lymphocytes ratio was higher in patients with large LNneg with borderline significance (0.03 [0–0.3] vs 0.02 [0–0.14]; P = 0.05), suggesting that large LNnegs may have increased formation of GC structures compared to small LNnegs (Fig. 5 D–F).
3.1.4 Analysis of GPX4 expression results According to the Kaplan-Meier Plotter database, increased expression of GPX4 mRNA was not significantly correlated with OS in GC patients ( Figure 4 A) ( P > 0.05), and the Lauren classification results showed that the increase of GPX4 mRNA expression was not correlated with the OS in gastrointestinal cancer ( Figure 4 B) and mixed GC ( Figure 4 D) patients ( P > 0.05), while OS showed a favorable trend with the increase of GPX4 mRNA low expression, which was statistically significant in diffuse GC patients ( Figure 4 C) ( P < 0.05). 3.1.5 Analysis of GPX5 expression results The Kaplan-Meier Plotter database results revealed that an increase in GPX5 mRNA expression in GC patients was significantly correlated with OS ( Figure 5 A) (P0.05), and Lauren classification results showed that an increase in GPX5 mRNA low expression in GC patients showed a favorable prognostic trend in OS.
The peak in the cancer rate was defined as the point at which there was a significant change in the lung cancer rates from an increasing trend to a decreasing trend, as identified by the Joinpoint regression program with p<0.05 considered to denote statistical significance (Kim et al., 2000).
One hour after CM injection, both groups showed a decreasing trend in RBF (both p < 0.05).
The coast started a decreasing trend in 2010 (APC = − 5.2, 95% CI: − 8.9, − 1.4, p < 0.05), while the rainforest showed a reduction amongst the entire study period (APC = − 4.3, 95% CI: − 7.2, − 1.3, p < 0.05).
The rate of hydronephrosis reached borderline significance in NC patients at 3 months after transplantation (p = 0.05).
A marginally significant OS difference was also noticed in high-quality than in low-quality TE inserted group in the subgroup analysis (100.0% vs. 71.4%, P = 0.05).
If at least one feature significantly differed across chemical concentrations as indicated by the ANOVA test (at least one DEG), data were then subjected to a statistical trend test (Williams’ Trend Test; p < 0.05; 100 permutations; Supplementary Table S.3 , Step 2).
marginally non-significantP = 0.05
A marginally non-significant effect of TMS was also found ( P = 0.05, cluster-corrected).
Otherwise, we examined univariate analysis results. To eliminate the impact of the borderline significant results, we considered P≤0.05 as significant (not P=0.051).
Meta-analysis on PET studies There was a marginally significant subgroup difference between the PET studies that controlled for covariates and the ones that did not (4 vs. 7 study groups, Q(1) = 3.72, p = 0.05).
At one of the 13 CpGs reported by Kallak et al., we found nominally significant ( p < 0.05) differential DNAme associated with SSRI exposure status in the placenta in the same direction as the original cord blood association: higher DNAme in SSRI-exposed cases.
Patients receiving etanercept monotherapy had less deterioration of PtGA and PtJP scores versus those assigned to methotrexate monotherapy, with a nominally significant treatment difference observed at almost all time points for PtGA and PtJP at weeks 12 and 36 ( p < 0.05; Fig. 1 ).
borderline significancep = 0.05
When considering the difference in the CIRs, the HD patients still exhibited higher rates of GI bleeding compared with the PD patients over the 16-year follow-up period, with borderline significance (0.3265 vs. 0.3240, p = 0.05) (Fig. 2 ).
borderline significanceP = 0.05
Consistently, in univariate Cox-regression analysis, baseline 53BP1 foci demonstrated borderline significance for predicting PSA-PFS under [ 177 Lu]Lu-PSMA RLT ( P = 0.05).
However, because a near-significant effect was observed in the latter case, we report that a significant difference (post-hoc Conover test, p<0.05) was present between patients on DMARD therapy (median 3, IQR 2-6) and patients receiving glucocorticoids (median 5, IQR 3-7) and combined NSAID + glucocorticoid therapy (median 5, IQR 3.3-7).
A borderline significant decrease was observed in all motility parameters VSL, VCL, VAP, DSL, DAP, ALH, BCF, LIN, STR, WOB in the EMR group at p = 0.05.
There were no predictive factor influencing the return to sports among all those studied (sex, body mass index, preoperative Tegner, meniscal lesion, graft rupture, or contralateral ACL rupture), although having a contralateral ACL rupture or graft rupture was at the edge of significance ( P = .05) ( Table 5 ).
By contrast, the same samples measured for OVA concentrations showed highly significant differences between all genotypes (log transformed concentration of Muc2 +/+ vs Muc2 +/- , -10.58 ± 0.06 vs -9.77 ± 0.24; P = .05; Muc2 +/+ vs Muc2 -/- , -10.58 ± 0.06 vs -8.06 ± 0.33; P = .0002; Muc2 +/- vs Muc2 -/- , -9.77 ± 0.24 vs -8.06 ± 0.33; P = .002) ( Figure 4 B ), indicating that loss of function of even 1 Muc2 allele significantly weakens intestinal barrier function.
Other exercise intensity variables were not different or had marginally insignificant differences between Case and Controls groups (0.10 ≤ p < 0.05; Table S‐A2 ). 3.4.
For the same slope length and rainfall intensity, highly significant power-function relationships (p<0.05) between sediment concentration and slope gradient were found except for one combination test, although the power exponents were different for different combinations of slope length and rainfall intensity ( Fig. 3 ).
For DALYs of lung cancer attributable to metabolic risks, the age-standardized DALY rate of Kazakhstan, Kyrgyzstan, Turkmenistan, Maldives, the Philippines, Thailand, Singapore, Bahrain, Slovakia, Belarus, and Ukraine showed a decreasing trend in the “B&R” countries from 1990 to 2019 (all p < 0.05).
The statistical analysis revealed a highly significant impact ( p < 0.05) of the number of cycles (C), as well as the treatment time per cycle (t) and the input oil pressure (P) on the reduction rates (RR) of the volatile molecules considered.
A numerically greater change from baseline in 1-hour postdose FEV 1 was evident for aclidinium/formoterol FDC 400/12 μg compared with aclidinium/formoterol FDC 400/6 μg at all timepoints, including 24 weeks, though the improvements did not reach statistical significance except at week 4 (p < 0.05).